{"id": "1356240121259905026", "creation": 1612187817.0, "user_id": "49616273", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 5, "reply_count": 3, "like_count": 19, "quote_count": 0}}, "text": "China's Clover Biopharmaceuticals said Mon it will initiate global Phase II and III clinical trials of its protein subunit-based #COVID19 #vaccine candidate in the first half of 2021. Clover expects to supply up to 1 billion doses a year based on global demand by the end of 2021. https://t.co/BGG9Izprwr", "first_save": 1634559108.199414, "hashtags": ["#COVID19", "#VACCINE"]}